Abstract
This paper analyses the potentially conflictual provisions of the Agreement on the Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the Convention on Biological Diversity (CBD) pertaining to plant genetic resources and intellectual property rights. It concludes that potential conflict between TRIPS and the CBD may be reconciled by remaining true to the over-arching principle of global welfare-maximisation in TRIPS and by utilising patent exemptions in appropriate circumstances. In so doing, consonance may be achieved with the objectives of the CBD in order to ensure appropriate international recognition of IPRs and also conservation and sustainable use of biodiversity.
Published Version
Join us for a 30 min session where you can share your feedback and ask us any queries you have